Cook LM - Search Results

1

Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.

Cook LM, Shay G, Araujo A, Lynch CC. Cook LM, et al. Cancer Metastasis Rev. 2014 Sep;33(2-3):511-25. doi: 10.1007/s10555-014-9494-4. Cancer Metastasis Rev. 2014. PMID: 24414228 Free PMC article. Review.

2

An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer.

Araujo A, Cook LM, Lynch CC, Basanta D. Araujo A, et al. Among authors: cook lm. Cancer Res. 2014 May 1;74(9):2391-401. doi: 10.1158/0008-5472.CAN-13-2652. Cancer Res. 2014. PMID: 24788098 Free PMC article.

3

Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling.

Gallaher J, Cook LM, Gupta S, Araujo A, Dhillon J, Park JY, Scott JG, Pow-Sang J, Basanta D, Lynch CC. Gallaher J, et al. Among authors: cook lm. Clin Exp Metastasis. 2014 Dec;31(8):991-9. doi: 10.1007/s10585-014-9674-1. Epub 2014 Aug 31. Clin Exp Metastasis. 2014. PMID: 25173680 Free PMC article.

4

Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer.

Cook LM, Araujo A, Pow-Sang JM, Budzevich MM, Basanta D, Lynch CC. Cook LM, et al. Sci Rep. 2016 Jul 14;6:29384. doi: 10.1038/srep29384. Sci Rep. 2016. PMID: 27411810 Free PMC article.

5

Size Matters: Metastatic Cluster Size and Stromal Recruitment in the Establishment of Successful Prostate Cancer to Bone Metastases.

Araujo A, Cook LM, Lynch CC, Basanta D. Araujo A, et al. Among authors: cook lm. Bull Math Biol. 2018 May;80(5):1046-1058. doi: 10.1007/s11538-018-0416-4. Epub 2018 Mar 29. Bull Math Biol. 2018. PMID: 29600344 Free PMC article.

6

Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.

Cook LM, Frieling JS, Nerlakanti N, McGuire JJ, Stewart PA, Burger KL, Cleveland JL, Lynch CC. Cook LM, et al. Oncogene. 2019 Oct;38(44):6959-6969. doi: 10.1038/s41388-019-0913-4. Epub 2019 Aug 13. Oncogene. 2019. PMID: 31409900 Free PMC article.

7

Neutrophils are mediators of metastatic prostate cancer progression in bone.

Costanzo-Garvey DL, Keeley T, Case AJ, Watson GF, Alsamraae M, Yu Y, Su K, Heim CE, Kielian T, Morrissey C, Frieling JS, Cook LM. Costanzo-Garvey DL, et al. Among authors: cook lm. Cancer Immunol Immunother. 2020 Jun;69(6):1113-1130. doi: 10.1007/s00262-020-02527-6. Epub 2020 Feb 29. Cancer Immunol Immunother. 2020. PMID: 32114681 Free PMC article.

8

Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.

McGuire JJ, Frieling JS, Lo CH, Li T, Muhammad A, Lawrence HR, Lawrence NJ, Cook LM, Lynch CC. McGuire JJ, et al. Among authors: cook lm. Nat Commun. 2021 Feb 1;12(1):723. doi: 10.1038/s41467-021-20962-6. Nat Commun. 2021. PMID: 33526787 Free PMC article.

9

Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer.

Araujo A, Cook LM, Frieling JS, Tan W, Copland JA 2nd, Kohli M, Gupta S, Dhillon J, Pow-Sang J, Lynch CC, Basanta D. Araujo A, et al. Among authors: cook lm. Cancers (Basel). 2021 Feb 8;13(4):677. doi: 10.3390/cancers13040677. Cancers (Basel). 2021. PMID: 33567529 Free PMC article.

10

Emerging roles for myeloid immune cells in bone metastasis.

Alsamraae M, Cook LM. Alsamraae M, et al. Among authors: cook lm. Cancer Metastasis Rev. 2021 Jun;40(2):413-425. doi: 10.1007/s10555-021-09965-3. Epub 2021 Apr 14. Cancer Metastasis Rev. 2021. PMID: 33855680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page